KindlyMD (NASDAQ:NAKA) Shares Gap Down - What's Next?

Key Points

• KindlyMD shares gapped down from $4.08 to $3.76 at market open, currently trading at $4.74 with a volume of over 2 million shares.
• Analysts from Maxim Group have given KindlyMD a "buy" rating with a target price set at $8.00, reflecting a consensus rating.
• For the last quarter, KindlyMD reported a loss of ($0.34) earnings per share and generated $0.41 million in revenue, with significant negative margins and return on equity.

KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) shares gapped down prior to trading on Monday . The stock had previously closed at $4.08, but opened at $3.76. KindlyMD shares last traded at $4.74, with a volume of 2,139,033 shares changing hands.

Analysts Set New Price Targets

Separately, Maxim Group initiated coverage on shares of KindlyMD in a research note on Wednesday, September 3rd. They issued a "buy" rating and a $8.00 price target on the stock. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $8.00.

KindlyMD Trading Down 29.4%

The company has a market capitalization of $1.05 billion, a P/E ratio of -3.23 and a beta of 33.96. The firm has a 50-day moving average of $9.16.

KindlyMD (NASDAQ:NAKA - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.34) EPS for the quarter. KindlyMD had a negative return on equity of 131.09% and a negative net margin of 244.00%.The company had revenue of $0.41 million for the quarter.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.